Literature DB >> 3486443

HLA antigens in narcolepsy and idiopathic central nervous system hypersomnolence.

G Poirier, J Montplaisir, F Décary, D Momège, A Lebrun.   

Abstract

Several studies have shown familial incidence of narcolepsy and idiopathic central nervous system (CNS) hypersomnia. HLA antigen studies performed in mongoloid and caucasoid narcoleptic patients on the A, B, and C loci have yielded conflicting results. The aim of this study is to document a possible association between the HLA system, including the DR locus and excessive daytime somnolence. Thirty-one narcoleptic patients and 10 idiopathic hypersomniac patients were selected and typed for 54 HLA antigens. A family with narcoleptic members in 3 generations was also studied. HLA-DR2 was found in 100% of narcoleptic patients. The frequency of HLA-A3 and B7, which are in linkage disequilibrium with DR2 was also increased in this group. Idiopathic hypersomniac patients showed an increase of HLA-Cw2, DR5, and B27, three antigens known to be in linkage disequilibrium. In the family study, narcoleptic patients were also HLA-DR2; moreover, 3 subjects, one of whom was narcoleptic, were HLA-DR2 as a result of recombination (i.e., genetic crossing-over). These results locate the hypothetic gene associated with narcolepsy more precisely, and indicate that narcolepsy and idiopathic CNS hypersomnolence are two different entities.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3486443     DOI: 10.1093/sleep/9.1.153

Source DB:  PubMed          Journal:  Sleep        ISSN: 0161-8105            Impact factor:   5.849


  9 in total

Review 1.  Genetics of narcolepsy and other sleep disorders.

Authors:  E Mignot
Journal:  Am J Hum Genet       Date:  1997-06       Impact factor: 11.025

2.  Narcolepsy-Associated HLA Class I Alleles Implicate Cell-Mediated Cytotoxicity.

Authors:  Mehdi Tafti; Gert J Lammers; Yves Dauvilliers; Sebastiaan Overeem; Geert Mayer; Jacek Nowak; Corinne Pfister; Valérie Dubois; Jean-François Eliaou; Hans-Peter Eberhard; Roland Liblau; Aleksandra Wierzbicka; Peter Geisler; Claudio L Bassetti; Johannes Mathis; Michel Lecendreux; Ramin Khatami; Raphaël Heinzer; José Haba-Rubio; Eva Feketeova; Christian R Baumann; Zoltán Kutalik; Jean-Marie Tiercy
Journal:  Sleep       Date:  2016-03-01       Impact factor: 5.849

3.  Taq I-generated HLA-DQ alpha polymorphism in Japanese patients with narcolepsy.

Authors:  K Matsuki; H Maeda; T Juji; H Inoko; A Ando; K Tsuji; Y Honda
Journal:  Immunogenetics       Date:  1988       Impact factor: 2.846

Review 4.  Central Disorders of Hypersomnolence: Focus on the Narcolepsies and Idiopathic Hypersomnia.

Authors:  Zeeshan Khan; Lynn Marie Trotti
Journal:  Chest       Date:  2015-07       Impact factor: 9.410

5.  HLA haplotypes, polysomnography, and pedigrees in a case series of patients with narcolepsy.

Authors:  R Hayduk; P Flodman; M A Spence; M K Erman; M M Mitler
Journal:  Sleep       Date:  1997-10       Impact factor: 5.849

Review 6.  Genetic factors in sleep disorders.

Authors:  J D Parkes; C B Lock
Journal:  J Neurol Neurosurg Psychiatry       Date:  1989-06       Impact factor: 10.154

Review 7.  Clinical and neurobiological aspects of narcolepsy.

Authors:  Seiji Nishino
Journal:  Sleep Med       Date:  2007-04-30       Impact factor: 3.492

8.  Idiopathic hypersomnia: a study of 77 cases.

Authors:  Kirstie N Anderson; Samantha Pilsworth; Linda D Sharples; Ian E Smith; John M Shneerson
Journal:  Sleep       Date:  2007-10       Impact factor: 5.849

9.  Risk of narcolepsy associated with inactivated adjuvanted (AS03) A/H1N1 (2009) pandemic influenza vaccine in Quebec.

Authors:  Jacques Montplaisir; Dominique Petit; Marie-Josée Quinn; Manale Ouakki; Geneviève Deceuninck; Alex Desautels; Emmanuel Mignot; Philippe De Wals
Journal:  PLoS One       Date:  2014-09-29       Impact factor: 3.240

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.